AstraZeneca - 2018 Heroes of Chemistry
3,210 views · Published 20 August 2018 · 3:44 · Indexed 6 November 2026
Channel: American Chemical Society · 2018 · Science & Technology
AstraZeneca: TAGRISSO TM (osimertinib) is a novel, targeted treatment for patients with EGFR-mutated non-small cell lung cancer. Osimertinib is approved in more than 75 countries. Subscribe! http://bit.ly/AmerChemSOc Facebook! https://www.facebook.com/AmericanChem... Twitter! https://twitter.com/ACSpressroom For ore information on Heroes of Chemistry, please visit the website: http://bit.ly/heroes-of-chemistry You might also like: 2017 Heroes of Chemistry: https://www.youtube.com/playlist?list=PLLG7h7fPoH8Jym-hI_gXIheoIos2pKonw ACS Lectureship Awards Series: https://www.youtube.com/playlist?list=PLLG7h7fPoH8Iz8Aocpu2PednfxYffGMFO 2016 Heroes of Chemistry: https://www.youtube.com/playlist?list=PLLG7h7fPoH8Ivs9TDTFhj2dg8CmROmS5X Prized Science: https://www.youtube.com/watch?v=JcHSthRHciI&list=PLLG7h7fPoH8IO6wJ5vhENd6-vHJYbN5vo Produced by the American Chemical Society, the world’s largest scientific society. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. Join the American Chemical Society! https://bit.ly/Join_ACS
More from this channel
-
4:50
Monodisperse Graphene Dispersions
-
6:16
Optically Probing DNA
-
4:38
Organic Photovoltaics
-
1:47
Grid View demo
-
5:35
C&EN Archives Demo
-
5:04
Ionic Liquids and Ionizing Radiation: Reactivity of Highly Energetic Species
-
4:30
Nanostructure Absorption
-
5:23
Interview with Dr. Craig W. Lindsley - September 25, 2009